AI-powered readingSave time. Increase confidence. Save costs.

Neurodegenerative diseases such as Alzheimer’s disease (AD) are entering a new era, with emerging therapies bringing new hope while increasing the demand for advanced, standardized imaging. Quantitative imaging can support confident clinical decision-making across the Alzheimer`s care pathway – from brain morphometry to aid differential diagnosis, to standardized amyloid PET assessment with Centiloid scoring, and integrated tau PET quantification to support disease characterization and therapy-related decision-making.

Al-powered automation and quantitative analysis help simplify complex workflows, reduce reading time, and deliver standardized, reproducible results. This enables clinicians to identify appropriate patients more efficiently, manage growing imaging workloads, and provide consistent, high-quality care with greater confidence.

For stroke patients, time is of the essence. Every minute saved can positively impact patient outcomes. That’s why it’s critical to save time along the entire stroke pathway – from first symptoms to treatment and follow‑up care. Stroke care does not happen in isolation. It follows interconnected patient pathways where imaging and clinical decision‑making support faster, informed action – during the acute event, throughout secondary prevention, and even before hospital arrival with the Mobile Stroke Unit (MSU)⁵. AI-powered solutions, comprehensive overviews with multimodality layout and several timepoints, patient triaging in worklists and immediate alerts help to be ahead of time. As an example, syngo.CT LVO Detection⁵ with automated support for emergency triage helps detect and flags suspected large vessel occlusions. syngo.CT Vessel Hyperdensities⁵ assists in automated localization and segmentation of LVOs.

Cardiovascular diseases remain the leading cause of death worldwide and continue to contribute to increasing costs in healthcare systems. To improve your personalized cardiovascular care delivery, support detection and risk assessments, enhance diagnostic confidence, and make well-informed therapy decisions we are committed to support you with AI-powered solutions. 

From the detection of coronary artery disease or structural heart disease to the analysis of myocardial infarction, our AI-powered reading solutions are designed to assist your diagnostic with automated workflows and AI-driven results. Like syngo.CT Coronary Cockpit⁵: It automatically segments and labels coronaries and visualizes as well as quantifies plaque types for the whole coronary tree or individual lesions. It also allows for placing stent markers for PCI planning purposes.

With AI-powered prostate reading solutions the specific DSA density and PI-RADs classification of potential lesions are calculated immediately and transferred to a pre-populated report. Automatic segmentation and volumetric assessments of the prostate gland save valuable time. All results are seamlessly transferred to the Ultrasound system enabling targeted biopsy of suspicious lesions and a confident TRUS guided biopsy procedure. Fully automated pelvic region contouring allows for a personalized precise radiotherapy planning. Rapid Results Technology archives automated and standardized results in your PACS, without the need for manual user interaction.

Our AI-powered chest CT reading solution provides automated pulmonary nodule detection, volumetric analysis, and comparison with prior examinations to support confident lung cancer detection and surveillance. Integrated reporting and workflow automation improve reading efficiency while supporting standardized screening programs and longitudinal patient management. Future capabilities such as Lung-RADS classification, longitudinal volumetric tracking, and AI-supported workflow integration will further strengthen standardized population-based lung cancer screening.

With AI-powered breast imaging solutions, we support radiologists across the entire breast cancer pathway – from screening and diagnosis to treatment planning. AI-assisted X-ray image analysis enhances lesion detection, improves workflow efficiency, and contributes to more consistent image interpretation. AI-powered contouring further supports precise target delineation for radiation therapy planning, enabling standardized workflows and personalized treatment strategies.

Neurodegenerative diseases such as Alzheimer’s disease (AD) are entering a new era, with emerging therapies bringing new hope while increasing the demand for advanced, standardized imaging. Quantitative imaging can support confident clinical decision-making across the Alzheimer`s care pathway – from brain morphometry to aid differential diagnosis, to standardized amyloid PET assessment with Centiloid scoring, and integrated tau PET quantification to support disease characterization and therapy-related decision-making.

Al-powered automation and quantitative analysis help simplify complex workflows, reduce reading time, and deliver standardized, reproducible results. This enables clinicians to identify appropriate patients more efficiently, manage growing imaging workloads, and provide consistent, high-quality care with greater confidence.